Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Lagnf A"'
Autor:
Nicholas Rebold, Sara Alosaimy, Jeffrey C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M. Jones, Jeremy J. Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 565-579 (2024)
Abstract Introduction Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers to discharge or who require prolonged parenteral antibiotic cour
Externí odkaz:
https://doaj.org/article/329fe8cb8de8423a9b5e528288ac79f6
Autor:
Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M. Lagnf, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L.V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Marco R. Scipione, Jing J. Zhao, Paige Witucki, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT Eravacycline is a synthetic fluorocycline approved by the U.S. Food and Drug Administration in 2018. This study aimed to describe clinical and microbiological outcomes in addition to associated adverse effects of eravacycline used in U.S. ho
Externí odkaz:
https://doaj.org/article/c7670c6ad2ab4a279e5ee3917f0e0369
Autor:
Nicholas Rebold, Abdalhamid M. Lagnf, Sara Alosaimy, Dana J. Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J. Kunz Coyne, Amer El Ghali, Kaylee E. Caniff, Michael P. Veve, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 1 (2023)
ABSTRACT The Centers for Disease Control and Prevention (CDC) categorized carbapenem-resistant Enterobacterales (CRE) infections as an “urgent” health care threat requiring public attention and research. Certain patients with CRE infections may b
Externí odkaz:
https://doaj.org/article/bb0cc000590f459e8dd74d0e4f76ae4d
Autor:
Sara Alosaimy, Taylor Morrisette, Abdalhamid M. Lagnf, Leonor M. Rojas, Madeline A. King, Benjamin M. Pullinger, Athena L. V. Hobbs, Nicholson B. Perkins, Michael P. Veve, Jeannette Bouchard, Tristan Gore, Bruce Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S. Lena Kang-Birken, Kyle C. Molina, Mark Biagi, Michael Pierce, Marco R. Scipione, Jing J. Zhao, Susan L. Davis, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT Forty-six patients were treated with eravacycline (ERV) for Acinetobacter baumannii infections, where 69.5% of isolates were carbapenem resistant (CRAB). Infections were primarily pulmonary (58.3%), and most patients received combination the
Externí odkaz:
https://doaj.org/article/3784b810c9054f3dafb994059224b8c7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sara Alosaimy, Noor L. Sabagha, Abdalhamid M. Lagnf, Evan J. Zasowski, Taylor Morrisette, Sarah C. J. Jorgensen, Trang D. Trinh, Ryan P. Mynatt, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 325-339 (2020)
Abstract Background Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) are associated with high morbidity and mortality. More in vitro, in vivo, and clinical data suggest that vancomycin (VAN) or daptomycin (DAP) combinat
Externí odkaz:
https://doaj.org/article/435be4c771d7494b9f96bac3d651a92b
Autor:
Sarah C. J. Jorgensen, Trang D. Trinh, Evan J. Zasowski, Abdalhamid M. Lagnf, Sahil Bhatia, Sarah M. Melvin, Samuel P. Simon, Joshua R. Rosenberg, Molly E. Steed, Sandra J. Estrada, Taylor Morrisette, Susan L. Davis, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 291-304 (2020)
Abstract Background The aim of this study was to evaluate the predictive performance of the INCREMENT-CPE (ICS), Pitt bacteremia score (PBS) and qPitt for mortality among patients treated with ceftazidime–avibactam for carbapenem-resistant Enteroba
Externí odkaz:
https://doaj.org/article/a418b4cd99f0401695ee735da7bc77bf
Autor:
Sarah C. J. Jorgensen, Kyle P. Murray, Abdalhamid M. Lagnf, Sarah Melvin, Sahil Bhatia, Muhammad-Daniayl Shamim, Jordan R. Smith, Karrine D. Brade, Samuel P. Simon, Jerod Nagel, Karen S. Williams, Jessica K. Ortwine, Michael P. Veve, James Truong, David B. Huang, Susan L. Davis, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 1, Pp 89-106 (2020)
Abstract Background We sought to determine the real-world incidence of and risk factors for vancomycin-associated acute kidney injury (V-AKI) in hospitalized adults with acute bacterial skin and skin structure infections (ABSSSI). Methods Retrospecti
Externí odkaz:
https://doaj.org/article/b1972c958ffe464ba5f0ed226230571c
Autor:
Manmatharayan, Arichena, Andrade-Machado, Rene, Marawar, Rohit, Lee, Paul, Lagnf, Abdalhamid, Souidan, Hassan, Ataya, Taha, Abdelhak, Farah, Thomas, Rohan, Fakhouri, Rami, Motii, Younes, Rehman, Sarah, Durban, Margerie, Parker, Dennis, Mohamed, Wazim, Elsayed, Mona
Publikováno v:
Journal of Epileptology; July 2024, Vol. 32 Issue: 1 p9-12, 4p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.